Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trial.

ABSTRACT:

SUBMITTER: Huhn S 

PROVIDER: S-EPMC5543255 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature